B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 36.45 SEK -4.2% Market Closed
Market Cap: 2.4B SEK

Wall Street
Price Targets

BINV Price Targets Summary
BioInvent International AB

Wall Street analysts forecast BINV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BINV is 90.1 SEK with a low forecast of 80.8 SEK and a high forecast of 105 SEK.

Lowest
Price Target
80.8 SEK
122% Upside
Average
Price Target
90.1 SEK
147% Upside
Highest
Price Target
105 SEK
188% Upside
BioInvent International AB Competitors:
Price Targets
TECX
AVROBIO Inc
286% Upside
RCKT
Rocket Pharmaceuticals Inc
433% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
38% Upside
IMMU
Mendus AB (publ)
329% Upside
SYRE
Spyre Therapeutics Inc
222% Upside
CSL
CSL Ltd
35% Upside
CPRX
Catalyst Pharmaceuticals Inc
47% Upside
KMDA
Kamada Ltd
119% Upside

Revenue
Forecast

Revenue Estimate
BioInvent International AB

For the last 8 years the compound annual growth rate for BioInvent International AB's revenue is -6%. The projected CAGR for the next 3 years is 134%.

-6%
Past Growth
134%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioInvent International AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
BioInvent International AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BINV's stock price target?
Price Target
90.1 SEK

According to Wall Street analysts, the average 1-year price target for BINV is 90.1 SEK with a low forecast of 80.8 SEK and a high forecast of 105 SEK.

What is BioInvent International AB's Revenue forecast?
Projected CAGR
134%

For the last 8 years the compound annual growth rate for BioInvent International AB's revenue is -6%. The projected CAGR for the next 3 years is 134%.

Back to Top